We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+16.63%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$30.8B
AUM Growth
+$5.31B
Cap. Flow
+$1.39B
Cap. Flow %
4.5%
Top 10 Hldgs %
6.07%
Holding
3,708
New
800
Increased
1,115
Reduced
1,029
Closed
741

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$187M
2
WMT icon
Walmart Inc
WMT
+$173M
3
DG icon
Dollar General
DG
+$171M
4
BMY icon
Bristol-Myers Squibb
BMY
+$164M
5
AMZN icon
Amazon
AMZN
+$162M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.5%
2 Technology 14.07%
3 Healthcare 12.37%
4 Industrials 9.06%
5 Financials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
3451
CALL
TAL Education Group
TAL
$6.28B
-13,000
Closed -$347K
TAL icon
3452
PUT
TAL Education Group
TAL
$6.28B
-10,000
Closed -$267K
TAP icon
3453
Molson Coors Class B
TAP
$8.01B
-65,347
Closed -$4.03M
TCRT icon
3454
Alaunos Therapeutics
TCRT
$4.47M
-756
Closed -$212K
TDG icon
3455
CALL
TransDigm Group
TDG
$66.4B
-2,000
Closed -$680K
TDG icon
3456
TransDigm Group
TDG
$66.4B
-3,328
Closed -$1.13M
TDOC icon
3457
CALL
Teladoc Health
TDOC
$1.16B
-9,000
Closed -$446K
TDOC icon
3458
Teladoc Health
TDOC
$1.16B
-326,297
Closed -$16.2M
TDOC icon
3459
PUT
Teladoc Health
TDOC
$1.16B
-6,000
Closed -$297K
TDS icon
3460
Telephone and Data Systems
TDS
$3.87B
-388,556
Closed -$12.6M
TECH icon
3461
Bio-Techne
TECH
$11.3B
-62,656
Closed -$2.27M
TEL icon
3462
CALL
TE Connectivity
TEL
$58.9B
-11,000
Closed -$832K
TEL icon
3463
PUT
TE Connectivity
TEL
$58.9B
-9,000
Closed -$681K
TEX icon
3464
CALL
Terex
TEX
$7.6B
-12,700
Closed -$350K
TEX icon
3465
PUT
Terex
TEX
$7.6B
-18,900
Closed -$521K
TG icon
3466
Tredegar Corp
TG
$278M
-27,135
Closed -$430K
TGTX icon
3467
TG Therapeutics
TGTX
$8.31B
-769,011
Closed -$3.15M
TLRY icon
3468
Tilray
TLRY
$666M
-1,079
Closed -$823K
TLT icon
3469
iShares 20+ Year Treasury Bond ETF
TLT
$45.5B
-13,747
Closed -$1.67M
TMO icon
3470
CALL
Thermo Fisher Scientific
TMO
$233B
-21,000
Closed -$4.7M
TMO icon
3471
Thermo Fisher Scientific
TMO
$233B
-21,772
Closed -$5.42M
TNDM icon
3472
CALL
Tandem Diabetes Care
TNDM
$1.55B
-17,000
Closed -$645K
TNDM icon
3473
PUT
Tandem Diabetes Care
TNDM
$1.55B
-22,100
Closed -$839K
TOVX icon
3474
Theriva Biologics
TOVX
$10.8M
-43
Closed -$6K
TREE icon
3475
CALL
LendingTree
TREE
$433M
-2,000
Closed -$439K

Similar funds

John Overdeck's Q1 2019 Portfolio in Review

As of Q1 2019, John Overdeck held 3,708 positions worth $30.8B, up 21% from $25.5B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

John Overdeck deployed $1.39B of net new capital in Q1 2019, opening 800 new positions and adding to 1,115 existing holdings. Its largest new stake was Dollar General: 1,470,962 shares worth $175M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Netflix, an estimated $243M trimmed.

  • John Overdeck's largest Q1 2019 buy was Dollar General: 1,470,962 shares worth $175M.
  • John Overdeck added most to AbbVie in Q1 2019, an estimated $187M increase.
  • John Overdeck's biggest Q1 2019 reduction was Netflix, cutting an estimated $243M.
  • John Overdeck fully exited Boeing in Q1 2019, selling an estimated $202M.
  • John Overdeck's ten largest holdings make up 6.1% of its $30.8B portfolio in Q1 2019.
  • John Overdeck opened 800 new positions and closed 741 in Q1 2019.
  • John Overdeck's portfolio value rose 21% quarter-over-quarter to $30.8B.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.